Sublingual Misoprostol With or Without Intravenous Tranexamic Acid During Hemorrhagic Cesarean Section
Status:
Recruiting
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
Purpose to evaluates the effects of sublingual misoprostol with or without intravenous
tranexamic acid (TA) on reducing post-partum hemorrhage during and after hemorrhagic cesarean
section.